AX Pharmaceutical Corp
- Manufacturer
- AX Pharmaceutical Corp
- Effective date
- 2018-06-04
- Label type
- BULK INGREDIENT
- Version
- 1
- Source
- legacy-cache
- Hydrated at
- 2026-08-02 00:55:09
Label at a glance#
ProductAX Pharmaceutical Corp
Active ingredientTAZAROTENE
Label structure1 sections
Label contents#
Full prescribing information#
Products#
Every source-derived product name is available through these pages.
- AX Pharmaceutical Corp
- TAZAROTENE
- WATER
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 62157-599 | 62157-599-01 |
Ingredients#
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| TAZAROTENE | 81BDR9Y8PS | ACTIB |
| WATER | 059QF0KO0R | IACT |
Source Document#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Trilitas | TAZAROTENE | Perfero Pharma, Inc. | 1cf1faef-73b8-4ab2-a4c8-521f0bd3fc10 | 2026-05-18 | Warnings, Adverse reactions | TAZAROTENE |
| FABIOR | TAZAROTENE | Mayne Pharma | ae0afed7-1d60-45fd-a08b-8db094618521 | 2026-03-03 | Warnings, Adverse reactions | TAZAROTENE |
| Tazarotene | TAZAROTENE | Sun Pharmaceutical Industries, Inc. | 478ff059-9d7b-438e-a64e-c853dfac2872 | 2025-12-19 | Warnings, Adverse reactions | TAZAROTENE |
| Tazorac | TAZAROTENE | Almirall, LLC | 4e4e4b81-420e-4492-8a74-80b692a80057 | 2025-11-13 | Warnings, Adverse reactions | TAZAROTENE |
| TAZORAC | TAZAROTENE | Almirall, LLC | 021744d1-a6d7-4ad6-99c2-7187c24e64c6 | 2025-11-13 | Warnings, Adverse reactions | TAZAROTENE |
| Tazarotene | TAZAROTENE | Sun Pharmaceutical Industries, Inc. | 34d79c31-1568-4797-a4f5-31200c7788db | 2025-07-07 | Warnings, Adverse reactions | TAZAROTENE |
| Tazarotene | TAZAROTENE | Cosette Pharmaceuticals, Inc. | fa5caf83-29d5-8229-b125-d7736928f132 | 2025-03-10 | Warnings, Adverse reactions | TAZAROTENE |
| Tazarotene | TAZAROTENE | Solaris Pharma Corporation | f1c98c4a-f101-4f3c-851a-39c827415c46 | 2025-01-02 | Warnings, Adverse reactions | TAZAROTENE |
| TAZAROTENE | TAZAROTENE | Bryant Ranch Prepack | 91264c0a-223c-47b7-b537-071944f25790 | 2024-11-11 | Warnings, Adverse reactions | TAZAROTENE |
| tazarotene | TAZAROTENE | Mayne Pharma Inc. | 0e337598-f589-483f-a2ae-be7c319d7454 | 2024-06-04 | Warnings, Adverse reactions | TAZAROTENE |
| TAZAROTENE | TAZAROTENE | Padagis Israel Pharmaceuticals Ltd | df5d65de-0693-4fd2-b335-f04ab1e201e7 | 2024-05-31 | Warnings, Adverse reactions | TAZAROTENE |
| TAZAROTENE | TAZAROTENE | Bryant Ranch Prepack | aa6fff2f-01c7-4669-be67-07cec82c768a | 2024-05-29 | Warnings, Adverse reactions | TAZAROTENE |
| Tazarotene | TAZAROTENE | Mayne Pharma | 0296f0e9-f940-45d9-987e-1ee26a7ca961 | 2024-03-05 | Warnings, Adverse reactions | TAZAROTENE |
| TAZAROTENE | TAZAROTENE | Padagis Israel Pharmaceuticals Ltd | ffd11dee-4266-4201-9573-1e82c2d30a63 | 2024-01-01 | Warnings, Adverse reactions | TAZAROTENE |
| TAZAROTENE | TAZAROTENE | Cosette Pharmaceuticals, Inc. | ecd718fd-c06e-4b3a-8aca-fa51e7c51a66 | 2023-11-29 | Warnings, Adverse reactions | TAZAROTENE |
| TAZAROTENE | TAZAROTENE | Cosette Pharmaceuticals, Inc. | 94749b8e-0d00-4257-a660-6d0fc8815fcf | 2023-11-29 | Warnings, Adverse reactions | TAZAROTENE |
| Arazlo | TAZAROTENE | Bausch Health US, LLC | d941ff25-c221-4a55-8012-0dcf3bbcbbd1 | 2023-09-26 | Warnings, Adverse reactions | TAZAROTENE |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
